Konecny GE, Lim PC, Santin AD, Gilbert L, et al. Carboplatin Plus Mirvetuximab Soravtansine In Platinum-Sensitive Ovarian Cancer: A Phase 2 Nonrandomized Clinical Trial. Clin Cancer Res 2026 Oct 21. doi: 10.1158/1078-0432.CCR-26-0238.
PMID: 42905759